As of October 2026 CRISPR Therapeutics has a market cap of โน516.13 Billion. This makes CRISPR Therapeutics the world's 3011th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 3rd, 2026 the market cap of CRISPR Therapeutics was reported to be: